Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes
about
Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice.Autonomic imbalance: prophet of doom or scope for hope?Differential impact of type-1 and type-2 diabetes on control of heart rate in mice.Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications)Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension.p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Diabetic neuropathy: cellular mechanisms as therapeutic targets.Inflammation: therapeutic targets for diabetic neuropathy.Mechanism of diabetic neuropathy: Where are we now and where to go?Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic EventsCyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients
P2860
Q34086993-45D3E3E5-182A-42F4-8C76-A3E57485D53FQ34188766-E6035BD7-465C-4D79-B91F-FB372D87CE58Q35069681-A85408C5-4D24-419B-8911-8489EACF5EAFQ36493953-F792F0A9-43E0-459F-8499-02106D97FF1DQ36740115-07F44B40-BC06-4DA5-892D-2C7C79B89EAFQ36797387-E99ECCDD-EAB9-4B79-81B4-E8E62CC7BED0Q37233114-1C3FE8E0-D1E6-4D38-93D9-8C0239DCE8CEQ37257009-61EE0D62-171B-4096-92F3-D20139DC1593Q37711062-4DE7F0FA-03FE-49F4-BD54-53F6862C2903Q37930962-D0416AD6-0220-402B-825D-3DC1548F7CA4Q38132718-7C689381-0022-40F5-BA0D-21BF55DEAEC2Q38213041-FF9497D4-8845-445C-B2AC-FCACE9D8E715Q40127983-DE546AEB-F632-4BAE-95FF-2BC1040257ADQ58700773-54DFD924-D6C2-4BE0-B02F-247B7056AAC6Q58885866-6339247C-14D6-4745-82F1-39F82A14F79C
P2860
Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of cyclooxygenase-2 ge ...... ction in experimental diabetes
@en
Effects of cyclooxygenase-2 ge ...... tion in experimental diabetes.
@nl
type
label
Effects of cyclooxygenase-2 ge ...... ction in experimental diabetes
@en
Effects of cyclooxygenase-2 ge ...... tion in experimental diabetes.
@nl
prefLabel
Effects of cyclooxygenase-2 ge ...... ction in experimental diabetes
@en
Effects of cyclooxygenase-2 ge ...... tion in experimental diabetes.
@nl
P2093
P2860
P1476
Effects of cyclooxygenase-2 ge ...... ction in experimental diabetes
@en
P2093
Aaron P Kellogg
Kimber Converso
Martin Stevens
Tim Wiggin
P2860
P304
P356
10.1152/AJPHEART.00678.2008
P577
2008-12-05T00:00:00Z